VijayShahMD

Gastroenterology • Rochester, MN

Biliary Tract Disease, Hepatology & Liver Transplantation

Professor, Internal Medicine, Mayo Medical School

Join to view full profile

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Shah's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511
Is this information wrong?

Education & Training

Yale-New Haven Medical CenterFellowship, Gastroenterology, 1994 - 1997
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1994
Northwestern University The Feinberg School of MedicineClass of 1991

Certifications & Licensure

MN State Medical License 1998 - 2025
IL State Medical License 1991 - 1996
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 2011
Fellow (FACG) American College of Gastroenterology

Clinical Trials

Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis Start of enrollment: 2014 Dec 01
Completed
Phase 2
Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH) Start of enrollment: 2014 Nov 03
Terminated
Phase 2
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium Start of enrollment: 2013 Jun 01
Completed
Use of F-652 in Patients With Alcoholic Hepatitis Start of enrollment: 2016 Feb 01
Completed
Phase 1, Phase 2
Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis Start of enrollment: 2020 Jul 10
Completed
Phase 2
Liver Cirrhosis Network Cohort Study Start of enrollment: 2022 Nov 14
Recruiting
Roles: Contact
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States Start of enrollment: 2023 Oct 11
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.
Winston Dunn, Yanming Li, Ashwani K Singal, Douglas A Simonetto, Luis A Díaz, Francisco Idalsoaga, Gustavo Ayares, Jorge Arnold, María Ayala-Valverde, Diego Perez, Jai...> ;Hepatology. 2024 Apr 12
1 citations
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.
Samer Gawrieh, Srinivasan Dasarathy, Wanzhu Tu, Patrick S Kamath, Naga P Chalasani, Craig J McClain, Ramon Bataller, Gyongyi Szabo, Qing Tang, Svetlana Radaeva, Bruce ...> ;Journal of Hepatology. 2024 Feb 10
Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis.
Yuanguo Wang, Xianghu Wang, Bing Bai, Aurpita Shaha, Xipu He, Yingzi He, Zhenqing Ye, Vijay H Shah, Ningling Kang> ;Hepatology. 2024 Jan 24
1 citations
Artificial Intelligence-Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application.
Hara, K., Penrice, D., Schmidt, K., Kassmeyer, B., Anstey, J., Tiede, D., Kraus, A., Kamath, P., Shah, V., Bajaj, J., Simonetto, D., Sordi Chara, B.> ;The American Journal of Gastroenterology. 2024 Feb 23
1 citations
ACG Clinical Guideline: Alcohol-Associated Liver Disease.
Bataller, R., Jophlin, L., Singal, A., Wong, R., Sauer, B., Terrault, N., Shah, V.> ;The American Journal of Gastroenterology. 2024 Jan 1
1 citations
Smartphone sensor data estimate alcohol craving in a cohort of patients with alcohol-associated liver disease and alcohol use disorder.
Tiffany Wu, Garrick Sherman, Salvatore Giorgi, Priya Thanneeru, Lyle H Ungar, Patrick S Kamath, Douglas A Simonetto, Brenda L Curtis, Vijay H Shah> ;Hepatology Communications. 2023 Dec 1
2 citations
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes.
Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, Gustavo Ayares, Oscar Corsi, Jorge Arnold, Macarena Cannistra, Danae Vio, Andrea Márquez-Lomas, Carolina...> ;Journal of Hepatology. 2024 Mar 1
Imaging of Alcohol-Associated Liver Disease.
Sharad Maheshwari, Chris N Gu, Melanie P Caserta, Camille A Kezer, Vijay H Shah, Michael S Torbenson, Sudhakar K Venkatesh, Menias, C., Fidler, J.> ;AJR. American Journal of Roentgenology. 2024 Jan 1
1 citations
Angiocrine Signaling in Sinusoidal Health and Disease.
Shawna A Cooper, Enis Kostallari, Vijay H Shah> ;Seminars in Liver Disease. 2023 Aug 1
4 citations
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.
Luis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, Francisco Idalsoaga, Jorge Arnold, María Ayala Valverde, Diego Perez, Jaime Gómez, Rodrigo Escarate, Alejandr...> ;JHEP Reports. 2023 Aug 1
Acute on Chronic Liver Failure in Patients with Alcohol-Associated Hepatitis: A Review.
Camille A Kezer, Douglas A Simonetto, Vijay H Shah> ;Clinics in Liver Disease. 2023 Aug 1
1 citations
Disproportionate increases in alcohol-associated hepatitis incidence in women and individuals of low socioeconomic status: A population-based study using the Rochester...
Joseph C Ahn, Chung-Il Wi, Seth Buryska, Priyadharshini Sivasubramaniam, William S Harmsen, Patrick S Kamath, Douglas A Simonetto, Young Juhn, Vijay H Shah> ;Hepatology Communications. 2023 Jun 1
1 citations
Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH.
Jiahui Li, Xin Lu, Zheng Zhu, Kyle J Kalutkiewicz, Taofic Mounajjed, Terry M Therneau, Sudhakar K Venkatesh, Yi Sui, Kevin J Glaser, Safa Hoodeshenas, Armando Manduca,...> ;Hepatology. 2023 Oct 1
3 citations
Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis.
Emma Avitabile, Alba Díaz, Carla Montironi, Martina Pérez-Guasch, Jordi Gratacós-Ginès, Helena Hernández-Évole, Roger K Moreira, Tejasav S Sehrawat, Harmeet Malhi, Pol...> ;Clinical Gastroenterology and Hepatology. 2023 Nov 1
2 citations
Emerging targets for therapy in ALD: Lessons from NASH.
Ashwani K Singal, Vijay H Shah, Harmeet Malhi> ;Hepatology. 2023 Mar 21
37 citations
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis.
Josepmaria Argemi, Maria U Latasa, Stephen R Atkinson, Ilya O Blokhin, Veronica Massey, Joel P Gue, Joaquin Cabezas, Juan J Lozano, Derek Van Booven, Aaron Bell, Sheng...> ;Nature Communications. 2023 Feb 10
17 citations
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
Meritxell Ventura-Cots, Josepmaria Argemi, Patricia D Jones, Carolin Lackner, Mohamed El Hag, Juan G Abraldes, Edilmar Alvarado, Ana Clemente, Samhita Ravi, Antonio Al...> ;Gut. 2022 Sep 1
8 citations
Review article: current and emerging therapies for acute alcohol-associated hepatitis.
Puru Rattan, Vijay H Shah> ;Alimentary Pharmacology & Therapeutics. 2022 Jul 1
2 citations
Machine Learning Techniques Differentiate Alcohol-Associated Hepatitis From Acute Cholangitis in Patients With Systemic Inflammation and Elevated Liver Enzymes.
Joseph C Ahn, Yung-Kyun Noh, Puru Rattan, Seth Buryska, Tiffany Wu, Camille A Kezer, Chansong Choi, Shivaram Poigai Arunachalam, Douglas A Simonetto, Vijay H Shah, Pat...> ;Mayo Clinic Proceedings. 2022 Jul 1
2 citations
A 2030 Vision for the Mayo Clinic Department of Medicine.
Natalie A Caine, Jon O Ebbert, Laura E Raffals, Lindsey M Philpot, Karna K Sundsted, Amanda E Mikhail, Meltiady Issa, Anne A Schletty, Vijay H Shah> ;Mayo Clinic Proceedings. 2022 Jul 1
8 citations
Therapeutic advances in alcohol-associated hepatitis.
Gyongyi Szabo, Mark Thursz, Vijay H Shah> ;Journal of Hepatology. 2022 Jun 1
3 citations
Omics and AI advance biomarker discovery for liver disease.
Tiffany Wu, Shawna A Cooper, Vijay H Shah> ;Nature Medicine. 2022 Jun 1
4 citations
Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate.
Ashwani K Singal, Andrea DiMartini, Lorenzo Leggio, Juan P Arab, Yong-Fang Kuo, Vijay H Shah> ;Alcohol and Alcoholism. 2022 Sep 10
Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
D Morales-Arráez, M Ventura-Cots, J Altamirano, J G Abraldes, M Cruz-Lemini, M R Thursz, S R Atkinson, S K Sarin, W Kim, R Chavez-Araujo, M F Higuera-de la Tijera, A K...> ;The American Journal of Gastroenterology. 2022 May 1
9 citations
Epigenetics of alcohol-related liver diseases.
Nawras W Habash, Tejasav S Sehrawat, Vijay H Shah, Sheng Cao> ;JHEP Reports. 2022 May 1
Join now to see all

Lectures

Evaluation of a Patient With Alcoholic Liver Disease
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
grand rounds
mayo clinic - 1/4/2014

Authored Content

Alcohol-Associated Liver Disease: A Global Problem in Need of Global SolutionsJune 2021

Press Mentions

Meet Yan Bi, M.D., Ph.D. — Physician and ScholarSeptember 1st, 2022
Minnesota Partnership Awards Five Collaborative Research Grants for 2022January 13th, 2022
We Are the WorldAugust 8th, 2019
Join now to see all